NCT02922127View on ClinicalTrials.gov

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
Contraception
Interventions
DRUG

Ulipristal Acetate

Daily use of Ulipristal Acetate

DRUG

Combined Oral Contraceptive Pill

Daily use of Oral Contraceptive Pill

Trial Locations (2)

10032

Columbia University Irving Medical Center, New York

10065

Weill Cornell Medical Center, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Columbia University

OTHER

NCT02922127 - Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation | Biotech Hunter | Biotech Hunter